CURX (Curanex Pharmaceuticals Inc Common Stock) Stock Analysis - AI Report

Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of May 21, 2026, CURX trades at $0.33 with a market cap of $8.53M and a P/E ratio of -1.91. CURX moved +0.00% today. Year to date, CURX is -9.92%; over the trailing twelve months it is flat. Its 52-week range spans $0.26 to $9.18. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on CURX?

Rallies AI research for CURX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

CURX Key Metrics

Key financial metrics for CURX
MetricValue
Price$0.33
Market Cap$8.53M
P/E Ratio-1.91
EPS$-0.17
Dividend Yield0.00%
52-Week High$9.18
52-Week Low$0.26
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$-4.23M
Gross Margin0.00%

Latest CURX News

CURX Analyst Consensus

CURX analyst coverage data. Average price target: $0.00.

Common questions about CURX

What is the AI research view on CURX?
Rallies AI research for CURX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for CURX?
Rallies AI research for CURX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is CURX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURX. It does not provide personalized investment advice.
CURX

CURX